News

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

02 August 2018

Analysis

Dolutegravir, contraception and women’s choice

Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).

21 December 2017

Analysis

The challenge of HIV drug resistance as prevalence exceeds 10%

As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.

29 September 2017

Analysis

Disagreement over best treatment regimes for pregnant women with HIV

A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.

28 July 2017

Analysis

Focusing on those with advanced HIV in the era of 'Treat All'

In the era of treat all, renewed emphasis is needed on the 39% of people living with HIV who start treatment late who are at an increased risk of deaths and opportunistic infections.

02 June 2017

Analysis

People living with HIV have increased risk of neurocognitive impairment when they grow older

In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older

You are here

News